Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFMWN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,094
Award facts
- Contract value 100% obligated
- $13,094.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $13,094.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COSENTYX (secukinumab) 300 mg pen auto-injectors in 2 ml formulation. This non-set-aside competitive award was issued on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. COSENTYX is a biologic immunosuppressant used to treat autoimmune and inflammatory conditions, making it a specialized pharmaceutical commodity typical of DLA medical supply procurement for military and federal healthcare systems.
This delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs and the Defense Health Agency. AmerisourceBergen Drug Corp maintains significant federal contracting capacity as a major pharmaceutical distributor, with a demonstrated track record of fulfilling competitive federal medical procurement requirements across multiple therapeutic domains through firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DB25FFMWN?
SPE2DB25FFMWN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 26, 2025.
How much is contract SPE2DB25FFMWN worth?
The government has obligated $13,094 on SPE2DB25FFMWN.
Is contract SPE2DB25FFMWN an order under another contract?
Yes. SPE2DB25FFMWN is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFMWN competed?
The extent of competition for SPE2DB25FFMWN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award